ApixabanLack of efficacy following off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1935卷 / 1期

关键词：

D O I：

10.1007/s40278-022-28884-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：89 / 89

相关论文

共 50 条

[21] ImiquimodLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1920 (1) : 254 - 254
[22] RuxolitinibLack of efficacy following off-label use: case report
Reactions Weekly, 2024, 2039 (1) : 502 - 502
[23] TocilizumabLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1887 (1) : 643 - 643
[24] DexamethasoneLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1936 (1) : 195 - 195
[25] OxcarbazepineLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1905 (1) : 409 - 409
[26] CabazitaxelLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1980 (1) : 102 - 102
[27] Catequentinib/sintilimabLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1958 (1) : 135 - 135
[28] Dexamethasone/tocilizumabLack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1968 (1) : 122 - 122
[29] AntineoplasticsPneumonia following off-label use and lack of efficacy: case report
Reactions Weekly, 2022, 1936 (1) : 69 - 69
[30] Aciclovir/ceftriaxoneLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1918 (1) : 19 - 19

← 1 2 3 4 5 →